Literature DB >> 10646687

Interactions between normal mammary epithelial cells and mammary tumour cells in a model system.

L H Quarrie1, J D Pitts, M E Finbow.   

Abstract

Normal mammary epithelial (NME) cells and MCF-7 cells aggregate and grow as spheroids when cultured on extracellular matrix derived from Engelbreth/ Holmes/Swarth (EHS) tumour. NME cells stop dividing and differentiate but MCF-7 cells continue to proliferate, although growth is counterbalanced by cell death. In mixed cultures of NME cells and MCF-7 cells, the two cell types form mixed aggregates but then segregate to form well separated domains, often joined by only a narrow neck of cells. In these mixed cultures the growth of MCF-7 cells is inhibited by a factor secreted by NME cells into the medium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10646687      PMCID: PMC6496196          DOI: 10.1111/j.1365-2184.1999.tb01353.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  21 in total

Review 1.  Molecular interactions of the syndecan core proteins.

Authors:  A C Rapraeger; V L Ott
Journal:  Curr Opin Cell Biol       Date:  1998-10       Impact factor: 8.382

2.  E-cadherin expression can alter the specificity of gap junction formation.

Authors:  D M Prowse; G P Cadwallader; J D Pitts
Journal:  Cell Biol Int       Date:  1997-12       Impact factor: 3.612

3.  Specific viral oncogenes cause differential effects on cell-to-cell communication, relevant to the suppression of the transformed phenotype by normal cells.

Authors:  M Bignami; S Rosa; G Falcone; F Tató; F Katoh; H Yamasaki
Journal:  Mol Carcinog       Date:  1988       Impact factor: 4.784

4.  Suppression of tumor cell growth by syndecan-1 ectodomain.

Authors:  M Mali; H Andtfolk; H M Miettinen; M Jalkanen
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

5.  Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle.

Authors:  N Boudreau; Z Werb; M J Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

6.  Growth inhibition of oncogene-transformed rat fibroblasts by cocultured normal cells: relevance of metabolic cooperation mediated by gap junctions.

Authors:  W Martin; G Zempel; D Hülser; K Willecke
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

7.  Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane.

Authors:  M H Barcellos-Hoff; J Aggeler; T G Ram; M J Bissell
Journal:  Development       Date:  1989-02       Impact factor: 6.868

8.  Branching morphogenesis of human mammary epithelial cells in collagen gels.

Authors:  F Berdichevsky; D Alford; B D'Souza; J Taylor-Papadimitriou
Journal:  J Cell Sci       Date:  1994-12       Impact factor: 5.285

9.  Extracellular matrix regulates whey acidic protein gene expression by suppression of TGF-alpha in mouse mammary epithelial cells: studies in culture and in transgenic mice.

Authors:  C Q Lin; P J Dempsey; R J Coffey; M J Bissell
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

10.  Extracellular matrix regulates expression of the TGF-beta 1 gene.

Authors:  C H Streuli; C Schmidhauser; M Kobrin; M J Bissell; R Derynck
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

View more
  2 in total

1.  Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice.

Authors:  Elizabeth F Redente; David J Orlicky; Ronald J Bouchard; Alvin M Malkinson
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

2.  Benign mammary epithelial cells enhance the transformed phenotype of human breast cancer cells.

Authors:  Joanna M Poczobutt; John Tentler; Xian Lu; Pepper J Schedin; Arthur Gutierrez-Hartmann
Journal:  BMC Cancer       Date:  2010-07-16       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.